Metabolic engineering boosts γ-decalactone yields in S. cerevisiae, highlighting the role of Faa2 in oleic acid conversion.
Lactones constitute a family of aroma compounds found in fruits, flowers and vegetables and are in high demand in the food industry. Previous studies have reported biotransformation of castor beans-extracted ricinoleic acid to γ-decalactone using oleaginous yeast Yarrowia lipolytica. Given the potential toxicities associated with castor beans, we have used a metabolic flux-engineering approach to produce γ-decalactone from oleic acid in Saccharomyces cerevisiae. Intracellular conversion of oleic acid to ricinoleic acid was achieved by the expression of oleate hydroxylase Fah12 from ergot fungus Claviceps purpurea. Glycerol-3-phosphate dehydrogenase-mediated glycerol synthesis was identified as the major metabolic diversion of oleic acid that negatively impacts γ-decalactone yields. Chemogenomic profiling analysis revealed that the tryptophan biosynthetic pathway provides resistance to γ-decalactone-mediated toxicity in yeast. Overexpression of tryptophan transporter Tat1 enhanced γ-decalactone production by about 3-fold. Deficiency of genes encoding the cytoplasmic fatty acyl CoA synthetases FAA1 or FAA4 alone did not significantly influence γ-decalactone production. However, deficiency of peroxisomal FAA2 drastically diminished the yield of γ-decalactone. Thus, this study uncovers the metabolic barriers to oleic acid-to-γ-decalactone conversion and identifies Faa2 as an essential element in this biotransformation.
No takes yet. Share an insight, caveat, or question.
Chia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: